Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Invested Capital (2016 - 2025)

United Therapeutics' Return on Invested Capital history spans 16 years, with the latest figure at 0.17% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.17%, up 1.0%, while the annual FY2025 figure was 0.17%, 1.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.17% at United Therapeutics, up from 0.17% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.18% in Q1 2022 and bottomed at 0.09% in Q1 2021.
  • The 5-year median for Return on Invested Capital is 0.16% (2024), against an average of 0.15%.
  • The largest annual shift saw Return on Invested Capital dropped -8bps in 2021 before it increased 9bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.11% in 2021, then skyrocketed by 40bps to 0.16% in 2022, then dropped by -8bps to 0.15% in 2023, then grew by 9bps to 0.16% in 2024, then grew by 5bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Return on Invested Capital are 0.17% (Q4 2025), 0.17% (Q3 2025), and 0.16% (Q2 2025).